Drugs / Enriched Hematopoietic Stem Cell Infusion
Enriched Hematopoietic Stem Cell Infusion
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1/2 | NCT00498160 | Jan 2005 → Aug 2024 | kidney failure | Talaris Therapeutics Inc. | Unknown | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Enriched Hematopoietic Stem Cell Infusion | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00498160 ↗ |
| Modality | Cell therapy | “facilitating cell-enriched HSCT” PMID 38601147 ↗ Mar 2024 |